Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dohee Kwon
High Tumoral PD-L1 Expression and Low PD-1+ or CD8+ Tumor-Infiltrating Lymphocytes Are Predictive of a Poor Prognosis in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
OncoImmunology
Oncology
Allergy
Immunology
Bronchovascular Injury Associated With Clinically Significant Hemoptysis After CT-guided Core Biopsy of the Lung: Radiologic and Histopathologic Analysis
PLoS ONE
Multidisciplinary
Related publications
PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
The Significance of Pd-L1 and Pd1 Receptors Expression in Patients With Diffuse B-Cell Large-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PD-L1 Expression in Basaloid Squamous Cell Lung Carcinoma: Relationship to PD-1+ and CD8+ Tumor-Infiltrating T Cells and Outcome
Modern Pathology
Forensic Medicine
Pathology
Tumour-Infiltrating Lymphocytes Are Correlated With Higher Expression Levels of PD-1 and PD-L1 in Early Breast Cancer
ESMO Open
Cancer Research
Oncology
Prognostic Implication of Programmed Death-1-Positive Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma
The Korean Journal of Pathology
Prognostic Impact of Pd-L1 Expression, Double Expressor Lymphoma, and Progression of Disease Within 24 Months in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer
Scientific Reports
Multidisciplinary
Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A2aR AS ONE OF NOVEL IMMUNE CHECKPOINTS, AND TUMOR-INFILTRATING LYMPHOCYTES IN DIFFUSE LARGE B-Cell LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology